, Columnist
Walgreens May Be Playing It Too Safe
While CVS aims to transform health care, its rival would double down on drugs.
This article is for subscribers only.
Walgreens Boots Alliance Inc. needs another deal.
That became clear after the FTC trimmed the drugstore giant's planned acquisition of Rite Aid Corp. and especially after rival CVS Health Inc. announced the $67.5 billion purchase of health insurer Aetna Inc.